In the study, the effects of peloid and paraffin treatments applied to symptomatic hallux rigidus patients on pain, functional status, quality of life and joint range of motion were evaluated and their effectiveness was compared.
Age range
35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Descriptive Characteristics of the Patients
Timeframe: Just before the treatment, both groups will be asked in the form of a short questionnaire.
Evaluation of Pain Severity
Timeframe: Patients were evaluated just before treatment. (1st measurement)
Evaluation of Functionality and Quality of Life
Timeframe: Patients were evaluated just before treatment. (1st measurement)
Evaluation of Quality of Life
Timeframe: Patients were evaluated just before treatment. (1st measurement)
Joint Range of Motion Measurement
Timeframe: Patients were evaluated just before treatment. (1st measurement)
Evaluation of Pain Severity
Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)
Evaluation of Functionality and Quality of Life
Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)
Evaluation of Quality of Life
Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)
Joint Range of Motion Measurement
Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)
Evaluation of Pain Severity
Timeframe: The patients were evaluated 1 month after the treatment. (3rd measurement)
Evaluation of Functionality and Quality of Life
Timeframe: The patients were evaluated 1 month after the treatment. (3rd measurement)
Evaluation of Quality of Life
Timeframe: The patients were evaluated 1 month after the treatment. (3rd measurement)
Joint Range of Motion Measurement
Timeframe: The patients were evaluated 1 month after the treatment. (3rd measurement)